# Corning Incorporated – Consensus ‘buy’ rating and 7.6% Upside Potential

- Link: https://www.directorstalkinterviews.com/corning-incorporated-consensus-buy-rating-and-7.6-upside-potential-2/4121145881
- Published: 2024-03-04T13:14:25+00:00
- Author: Charlotte Edwards

**Corning Incorporated** which can be found using ticker (GLW) now have 10 market
analysts covering the stock. The analyst consensus now points to a rating of ‘buy’.
The range between the high target price and low target price is between $40.00 and
$29.00 and has a mean target at $34.70. Given that the stocks previous close was
at $32.24 and the analysts are correct then we can expect a percentage increase 
in value of 7.6%. The day 50 moving average is $31.27 and the 200 day MA is $31.13.
The market cap for the company is 27.70B. The current share price for the company
is: $32.45 USD

 The potential market cap would be $29,808,452,694 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 47.72, revenue per share of $14.84
and a 2.85% return on assets.

Corning Incorporated is a materials science technology and innovation company. The
Company operates through five segments: Optical Communications, Display Technologies,
Specialty Materials, Environmental Technologies and Life Sciences. The Optical Communications
segment manufactures carrier network and enterprise network components for the telecommunications
industry. The Display Technologies segment manufactures glass substrates for flat
panel liquid crystal displays and other high-performance display panels. Its Specialty
Materials segment is engaged in manufacturing products that provide material formulations
for glass, glass ceramics and fluoride crystals to meet demand for customer needs.
Its Environmental Technologies segment manufactures ceramic substrates and filters
for emission control systems. Its Life Sciences segment manufactures glass and plastic
labware, equipment, media, serum and reagents enabling workflow solutions for drug
discovery and bioproduction.

Share on:
